A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
DualityBio Inc.
University of Miami
Jiangsu HengRui Medicine Co., Ltd.
University of Chicago
The Netherlands Cancer Institute
Daiichi Sankyo
Eastern Cooperative Oncology Group
Mayo Clinic
University of Ulm
City of Hope Medical Center
Kirby Institute
Masonic Cancer Center, University of Minnesota
University of California, San Francisco
Philogen S.p.A.
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Philogen S.p.A.
Abbott